Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Merck & Co., Inc. (MRK) had Cost of Goods Sold of $5.55B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$16.40B |
|
$2.96B |
|
|
Cost of Goods Sold |
$5.55B |
$10.85B |
|
$12.34B |
|
$4.07B |
|
$-645.00M |
|
$3.42B |
|
$3.63B |
|
$2.96B |
|
$2.96B |
|
$2.96B |
|
$3.20B |
|
$4.07B |
|
-- |
|
-- |
|
2.49B |
|
-- |
|
$1.19 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|